Illumina to Acquire SomaLogic for $350 Million, Expanding into Proteomics and Precision Medicine
Illumina, Inc.
Posts Tagged ‘NASDAQ:ILMN’
Top 10 Healthcare AI Stocks to Buy According to Hedge Funds
“Healthcare is the most underappreciated AI beneficiary,” said Ark Invest CEO Cathie Wood in a recent statement that’s reverberating across Wall Street.
Illumina, Inc. (ILMN): A Bull Case Theory
We came across a bullish thesis on Illumina, Inc. (ILMN) on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on ILMN.
Canaccord Raises Price Target Of Illumina, Inc. (ILMN).
Illumina, Inc. (NASDAQ:ILMN) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds.
11 Best Genomics Stocks to Buy According to Hedge Funds
Genomics is the study of genes and how they operate.
Does Illumina (ILMN) Have Good Long-Term Growth Prospects?
Diamond Hill Capital, an investment management company, released its “Mid Cap Strategy” investor letter for the first quarter of 2025.
Stifel Affirms Buy Rating on Illumina (ILMN) Stock
Analysts at Stifel are bullish about Illumina, Inc.’s (NASDAQ:ILMN) prospects despite the stock capitulating 36% year to date.
15 Small-Cap Healthcare Stocks Hedge Funds Are Buying
The U.S. healthcare sector has performed better in 2025 compared to the broader market.
Illumina, Inc. (NASDAQ:ILMN) Q1 2025 Earnings Call Transcript
Operator: Good day ladies and gentlemen, and welcome to the First Quarter 2025 Illumina Earnings Conference Call. At this time, all participants are in a listen only mode.
Here’s Why Artisan Mid Cap Fund Decided to Exit Illumina (ILMN)
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Should You Hold Illumina (ILMN)?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” first quarter 2025 investor letter.
15 Recent Activist Investor Campaigns
Economic uncertainty and market volatility are some of the factors fueling activist investor campaigns in 2025.
12 Best Diagnostics Stocks to Invest In Right Now
According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.
15 Best Biotech Stocks to Buy According to Billionaires
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
Jim Cramer’s Latest Lightning Round: 7 Stocks in Focus
On Thursday, Jim Cramer, the host of Mad Money, pointed out that the ongoing fears surrounding President Donald Trump's aggressive tariff policies continued to impact the market...
Why These 15 Large-Cap Stocks Are Plunging So Far In 2025
The big and large-cap stocks have spearheaded the rally in the past two years, but Wall Street’s expectations have gotten ahead of many of their fundamentals.
What Makes Illumina (ILMN) an Attractive Opportunity?
Brown Advisors, an investment management company, released its “Brown Advisors Global Leaders Strategy” fourth quarter 2024 investor letter.
What Makes Illumina (ILMN) a Long Term Bet?
Baron Funds, an investment management company, released its “Baron Fifth Avenue Growth Fund” fourth quarter 2024 investor letter.
Top 10 AI Stocks Buzzing on Latest News
Investors are continuing to assess the impact of new LLMs in the AI industry. X.
Jim Cramer Discusses These 10 Stocks & Dissects President Trump’s China Tariffs
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed China's retaliatory actions against President Trump's tariffs.
Illumina, Inc. (NASDAQ:ILMN) Q4 2024 Earnings Call Transcript
Illumina, Inc. (NASDAQ:ILMN) Q4 2024 Earnings Call Transcript February 6, 2025Illumina, Inc. misses on earnings expectations.
35 Non-Tech AI Opportunities Amid DeepSeek Selloff
Investors are searching for safer ways to capitalize on the AI boom beyond traditional tech stocks.
15 Stocks Targeted By Activist Hedge Funds
Shareholder activism continued at a record pace in 2024 as activist hedge funds pushed for strategic changes in various companies to unlock hidden value.
14 Stocks That Jim Cramer Recently Talked About
In his latest appearance on CNBC's Squawk on the Street, Jim Cramer continued to talk about the incoming Trump administration's tariffs.
Wells Fargo’s Best Growth Stocks: 28 Stocks With The Highest Consensus EPS Growth Estimates
With the interest rate cycle kicking off in the US, stocks that are exposed to consumer and business spending are starting to see a favorable economic outlook.
10 Best Immunotherapy Stocks to Buy Now
The global immunotherapy drugs market is rapidly expanding, with projections to grow from $240 billion in 2023 to $1.3 trillion by 2033.
UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors
With the third quarter of the 2024 earnings season underway, Wall Street is dealing with a changing stock market environment.
Here’s Why You Should Invest in Illumina (ILMN)
Baron Funds, an investment management firm, released its “Baron Global Advantage Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Illumina, Inc. (NASDAQ:ILMN) Q3 2024 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Third Quarter 2024 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode.
Is this the Best Time to Add Illumina (ILMN)?
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Illumina, Inc. (ILMN): A Bull Case Theory
We came across a bullish thesis on Illumina, Inc. (ILMN) on Ocean Road Capital’s Substack by Ocean Road Capital.
10 Cheap Robotics Stocks To Buy
The progress of Western civilization is built on industrialization.
Shake-Up Alert: 40 Companies Facing Activist Pressure
The equity market has been on a roll, rallying by 10% in the first half of 2024, adding to the 24% gain registered in 2024.
Illumina, Inc. (NASDAQ:ILMN) Q2 2024 Earnings Call Transcript
Operator: Good day ladies and gentlemen and welcome to the Second Quarter 2024 Illumina Earnings Conference Call. At this time, all participants are in a listen-only mode.
Here’s Why You Should Add Illumina (ILMN) to Your Portfolio
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” second quarter 2024 investor letter. A copy of the letter can...
Should You Consider Adding Illumina (ILMN) to Your Portfolio?
Ensemble Capital Management, an investment management company, released its second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Illumina, Inc. (NASDAQ:ILMN) Q1 2024 Earnings Call Transcript
Illumina, Inc. misses on earnings expectations. Reported EPS is $-0.79245 EPS, expectations were $0.03. Illumina, Inc.
14 Best Medical Device Stocks To Buy Now
In this article, we will discuss the 14 Best Medical Device Stocks To Buy Now.
Hedge Funds and Insiders Are Buying These 5 Stocks
This article presents an overview of Hedge Funds and Insiders Are Buying These 5 Stocks. For a detailed overview of such stocks, read our article, Hedge Funds and Insiders ...
10 Biggest Stocks Targeted By Activist Investors Right Now
In this article, we're going to take a look at 10 biggest stocks targeted by activist investors right now.
Reasons for the Decline of Illumina (ILMN)
Baron Funds, an investment management company, released its “Baron Opportunity Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Do You Believe in the Growth Prospects of Illumina (ILMN)?
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” fourth quarter 2023 investor...
Illumina, Inc. (NASDAQ:ILMN) Q4 2023 Earnings Call Transcript
Illumina, Inc. beats earnings expectations. Reported EPS is $0.14, expectations were $0.01. Illumina, Inc.
Jim Cramer is Bearish on These 5 Stocks
This article presents an overview of Jim Cramer is Bearish on These 5 Stocks. For a detailed overview of such stocks, read our article Jim Cramer is Bearish on These 12 Stocks...
Illumina (ILMN) Leads the Market With 80% Share
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter 2023 investor letter.
Here’s Why Polen Focus Growth Sold Illumina (ILMN)
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” fourth quarter 2023 investor letter.
Here’s How the New AI Algorithm Helps Illumina (ILMN)
Ensemble Capital Management, an investment management company, released its fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
5 Best Genomics Stocks To Buy Now
In this piece, we will take a look at the five best genomics stocks to buy now.
12 Best Medical Technology Stocks To Buy Now
In this article, we discuss 12 of the best medical device stocks to buy now.
